Zeng found that high ARD1 expression correlated positively with the survival rate of breast cancer patients and negatively with lymph node metastasis, indicating that ARD1 may enhance prognosis by inhibiting cancer cell migration and invasion. Here, NAA10 is linked to breast cancer.